New acid reflux drug shows promise in healing esophagus damage
NCT ID NCT06953986
First seen Mar 08, 2026 · Last updated May 14, 2026 · Updated 12 times
Summary
This study tests two doses of vonaprazan (10 mg and 20 mg) against esomeprazole (40 mg) to see which heals moderate-to-severe acid reflux damage in the esophagus after 8 weeks. About 414 adults with confirmed reflux esophagitis will take one pill daily. The goal is to find a more effective treatment for heartburn and regurgitation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asian Institute of Gastroenterology /Aig Hospitals
RECRUITINGHyderabad, Telangana, 500082, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.